This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

Funds

5

Vintages

2023 to 2025

Reported GAV

$100Mgross asset value on Form ADV; never dry powder

Funds with fundraising evidence

0derived

Investments

3

Portfolio companies

3

Investments, 12m

1

Partner-attributed

2

People

1

Investment professionals

1derived

Co-investors

0derived

LP relationships

0

Latest Form D

Mar 20, 2025

Latest ADV filing

Mar 28, 2024

Website

nexusneurotech.com

• Occurred

  Oct 26, 2023
  Adviser's first ADV filing

  Nexus Neurotech, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)

  Form ADVobserved 6 days ago

Also named here, with no published line of their own (reach them through the firm): Jordi Parramon (Managing Member).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Graph

Venture Capital

Canonical id

dfx:vc:0f68d73e-5881-4181-a22d-d6c64fdb0e19

First observed

Sep 12, 2026

Last observed

Sep 17, 2026 39 h ago

Source families

Federal regulator filings, Firm and issuer disclosures

2 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.

Resolution

Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.